 Glenmark Conclude Legal Dispute for GlaxoSmithKline Malarone PatentIndia-based Glenmark Pharmaceuticals Ltd. announced agreement to conclude legal dispute over GlaxoSmithKline Plc. patent of malaria treatment drug Malarone.
04-12-2010 |
18:22 hs.
|
According to the agreement, Glenmark can market their version of the drug, known as Atovaquone+Proguanil, from 3Q 2011, previous royalty payments to the British company. The drug, however, will be launched on 2012. Malarone had U.S. sales during 2009 of 56 million dollars.  Publish comment:
|
Estimated reading time: 0:12
Word count: 288
|
